Ga-68 PSMA-11 improves outcomes in prostate cancer patients
PET with a gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA)-11 radiotrace...Read more on AuntMinnie.comRelated Reading:
Lantheus gets FDA nod for Pylarify PET agent for prostate cancer
Hoag launches PET trials for prostate cancer, myeloma
Novel radiotracer shows promise for prostate imaging
FDA makes history with approval of Ga-68 PSMA-11 PET
Point Biopharma to use Lantheus' PyL in clinical trial
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news